Disclaimer The following guidelines are based on the best evidence available at the time of publication and caution should be exercised when interpreting data where there is a limited evidence base. It may be necessary to depart from the guidelines in the interests of specific patients and circumstances.
European guidelines for topical photodynamic therapy part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses
Version of Record online: 26 NOV 2012
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Volume 27, Issue 6, pages 672–679, June 2013
How to Cite
Morton, C.A., Szeimies, R.-M., Sidoroff, A. and Braathen, L.R. (2013), European guidelines for topical photodynamic therapy part 2: emerging indications – field cancerization, photorejuvenation and inflammatory/infective dermatoses. Journal of the European Academy of Dermatology and Venereology, 27: 672–679. doi: 10.1111/jdv.12026
Conflict of interest CA Morton has received speaker honoraria from Galderma and served as a consultant to Almirall and Leo Pharma. RM Szeimies has served as a consultant for, and has received speakers' honoraria and financial support to perform clinincal trials from Almirall, Biofrontera, Galderma, Leo, photonamic and Spirig. The other authors declare no conflicts of interest. [Correction added on 30 November 2012, after first online publication: conflict of interest statement was amended.]
Funding sources None declared.
- Issue online: 8 MAY 2013
- Version of Record online: 26 NOV 2012
- Received: 27 June 2012; Accepted: 03 October 2012
- 18Photodynamic therapy for actinic keratoses in organ transplant recipients. J Eur Acad Dermatol Venereol2012; DOI: 10.1111/J.1468-3083.2011.04356., , et al. .
- 33The use of photodynamic therapy in Dermatology: results of a consensus conference. J Drugs Dermatol2006; 5: 140–154., , et al.
- 40Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol2003; 2: 501–504., .
- 41Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol2004; 6(Suppl): S6–S9., , et al.
- 43ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol2004; 3: S32–S35., , , .
- 49Comparative study of aminolevulinic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts. Photomed Laser Surg2005; 31: 51–53., .
- 58Evaluation of photodynamic therapy using topical aminolaevulinic acid hydrochloride in the treatment of condyloma acuminate: a comparative, randomized clinical trial. Photodermatol Photoimmunol Photomed2009; 25: 293–297., , , , , .
- 59Adjuvant photodynamic therapy does not prevent recurrence of condylomata acuminata after carbon dioxide laser ablation-A phase III, prospective, randomized, bicentric, double-blind study. Dermatol Surg2009; 35: 757–764., , et al.
- 62Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. Clin Exp Dermatol2006; 31: 634–637., .
- 68Aminolaevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmet Dermatol2005; 18: 31–36..
- 70Enhanced efficacy photodynamic therapy after fractional resurfacing: fractional photodynamic rejuvenation. J Drugs Dermatol2007; 6: 818–820., , , .
- 71A prospective split-face double-blind randomized placebo-controlled trial to assess the efficacy of methyl aminolevulinate + red-light in patients with facial photodamage. J Eur Acad Dermatol Venereol2011; 25: 49–58., , , , .
- 74Response of vulval lichen sclerosus and squamous hyperplasia to photodynamic treatment using sustained topical delivery of aminolaevulinic acid from a novel bioadhesive patch system. Photodermatol Photoimmunol Photomed2009; 25: 111–113., , et al.
- 77Photodynamic therapy for perioral dermatitis. J Drugs Dermatol2006; 5: 12–16., .
- 80Photodynamic therapy for molluscum contagiosum infection in HIV-co-infected patients: review of 6 patients. J Drugs Dermatol2003; 2: 637–639..
- 91A cost analysis of photodynamic therapy with methyl aminolevulinate and imiquimod compared with conventional surgery for the treatment of superficial basal cell carcinoma and Bowen’s disease of the lower extremities. J Eur Acad Dermatol Venereol2010; 24: 1431–1436., , , , .